Appadurai MI, Alsafwani ZW, Chaudhary S, Shah A, et al. Ixazomib triggers autophagic degradation of MUC5AC/integrin-beta4 and inhibits non-small cell lung cancer progression. Cancer Lett 2026 Feb 28:218333. doi: 10.1016/j.canlet.2026.218333.
PMID: 41771342